Management of cancer patients during COVID-19 pandemic at developing countries
Abstract
Cancer patient care requires a multi-disciplinary approach and multiple medical and ethical considerations. Clinical care during a pandemic health crisis requires prioritising the use of resources for patients with a greater chance of survival, especially in developing countries. The coronavirus disease 2019 crisis has generated new challenges given that cancer patients are normally not prioritised for admission in critical care units. Nevertheless, the development of new cancer drugs and novel adjuvant/neoadjuvant protocols has dramatically improved the prognosis of cancer patients, resulting in a more complex decision-making when prioritising intensive care in pandemic times. In this context, it is essential to establish an effective and transparent communication between the oncology team, critical care, and emergency units to make the best decisions, considering the principles of justice and charity. Concurrently, cancer treatment protocols must be adapted to prioritise according to oncologic response and prognosis. Communication technologies are powerful tools to optimise cancer care during pandemics, and we must adapt quickly to this new scenario of clinical care and teaching. In this new challenging pandemic scenario, multi-disciplinary work and effective communication between clinics, technology, science, and ethics is the key to optimising clinical care of cancer patients.
Más información
Título según WOS: | Management of cancer patients during COVID-19 pandemic at developing countries |
Título de la Revista: | WORLD JOURNAL OF CLINICAL CASES |
Volumen: | 8 |
Número: | 16 |
Editorial: | BAISHIDENG PUBLISHING GROUP INC |
Fecha de publicación: | 2020 |
Página de inicio: | 3390 |
Página final: | 3404 |
DOI: |
10.12998/wjcc.v8.i16.3390 |
Notas: | ISI |